Chapter 1. 23-Valent Pneumococcal Polysaccharide Vaccine Market – Scope & Methodology

1.1. Market Segmentation

1.2. Assumptions

1.3. Research Methodology

1.4. Primary Sources

1.5. Secondary Sources

Chapter 2. 23-Valent Pneumococcal Polysaccharide Vaccine Market – Executive Summary

2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)

2.2. Key Trends & Insights

2.3. COVID-19 Impact Analysis

      2.3.1. Impact during 2023 – 2030

      2.3.2. Impact on Supply – Demand

Chapter 3. 23-Valent Pneumococcal Polysaccharide Vaccine Market – Competition Scenario

3.1. Market Share Analysis

3.2. Product Benchmarking

3.3. Competitive Strategy & Development Scenario

3.4. Competitive Pricing Analysis

3.5. Supplier - Distributor Analysis

Chapter 4. 23-Valent Pneumococcal Polysaccharide Vaccine Market - Entry Scenario

4.1. Case Studies – Start-up/Thriving Companies

4.2. Regulatory Scenario - By Region

4.3 Customer Analysis

4.4. Porter's Five Force Model

       4.4.1. Bargaining Power of Suppliers

       4.4.2. Bargaining Powers of Customers

       4.4.3. Threat of New Entrants

       4.4.4. Rivalry among Existing Players

       4.4.5. Threat of Substitutes

Chapter 5. 23-Valent Pneumococcal Polysaccharide Vaccine Market - Landscape

5.1. Value Chain Analysis – Key Stakeholders Impact Analysis

5.2. Market Drivers

5.3. Market Restraints/Challenges

5.4. Market Opportunities

Chapter 6. 23-Valent Pneumococcal Polysaccharide Vaccine Market - By Type

6.1. Pre-filled Syringe

6.2. Single Dose Vial

Chapter 7. 23-Valent Pneumococcal Polysaccharide Vaccine Market -  By Age Group

7.1. 2-10 Years

7.2. 10-64 Years

7.3. 64+ Years

Chapter 8. 23-Valent Pneumococcal Polysaccharide Vaccine Market - By Distribution

8.1. Hospitals

8.2. Clinics

8.3. Others

Chapter 9. 23-Valent Pneumococcal Polysaccharide Vaccine Market – By Region

9.1. North America

9.2. Europe

9.3.The Asia Pacific

9.4.Latin America

9.5. Middle-East and Africa

Chapter 10. 23-Valent Pneumococcal Polysaccharide Vaccine MARKET– Company Profiles – (Overview, Product Portfolio, Financials, Developments)

10.1. Company 1

10.2. Company 2

10.3. Company 3

10.4. Company 4

10.5. Company 5

10.6. Company 6

10.7. Company 7

10.8. Company 8

10.9. Company 9

10.10. Company 10

Download Sample